pimpleyellow0
About
Astragaloside Intravenous reduces puromycin aminonucleoside-induced podocyte cytoskeleton injury through the Wnt/PCP walkway.
Astragaloside Intravenous reduces puromycin aminonucleoside-induced podocyte cytoskeleton injury through the Wnt/PCP walkway.